US Copyright Office to conduct review

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

US Copyright Office to conduct review

Pallante Maria

During an AIPLA Annual Meeting luncheon keynote, US Register of Copyrights Maria Pallante said that the Copyright Office received a request from the Senate Judiciary Committee to research and provide information about copyright protection and software

Pallante Maria

The Committee asked the Office to look at how consumers can lawfully use products that are deeply integrated with copyrighted software.

Some other questions included whether and to what extent: 1) the design, distribution and legitimate use of products are being enabled or frustrated by copyright law to software within the products; 2) innovative services are being enabled or frustrated by copyright law as applied to these everyday products; and 3) legitimate interests and business models for copyright owners and users could be undermined or improved with changes to the copyright law.

The Committee also asked the Copyright Office to identify how copyright intersects with other areas of law and how it affects products that rely on software functions.

more from across site and SHARED ros bottom lb

More from across our site

Julia Bishop is director of IP at Twilio in the US
Hellberg is an IP director at Essity in Sweden
Palińska is the business & IP law lead at CD Projekt Red in Poland
Teemu Itälä is head of legal and compliance for technology standards at Nokia in Finland
Schwitulla is the head of litigation management at Nokia in Germany
David Degen is senior IP counsel at Novartis, Switzerland
Demetrio Roberto Cavicchia is an IP director at Angelini Pharma in Italy
Almeida is the IP group leader at Bosch in Brazil
Amanda Luz is brand protection manager - global at Adidas in the US
Samantak Ghosh is vice president of IP at Avere Therapeutics in the US
Gift this article